Return on Assets (ROA): 4.30%
Is the return on assets (ROA) high or low?
The return on assets (ROA) of 4.30% is 48% below its 5-year average of 8.21%, near the low end of its 5-year range (2.87%–11.86%).
As of Saturday, June 27, 2026. 5.39% below its 12-month average of 4.54%.
TECH Return on Assets (ROA) Chart
Annual fiscal-year return on assets; no daily interpolation.
TECH Average Return on Assets (ROA) Chart
TECH Current vs Average Return on Assets (ROA) Chart
TECH Return on Assets (ROA) Metrics
RETURN ON ASSETS (ROA)
4.30%
RETURN ON ASSETS (ROA) AVG TTM
4.54%
RETURN ON ASSETS (ROA) AVG 3Y
7.94%
RETURN ON ASSETS (ROA) AVG 5Y
8.21%
RETURN ON ASSETS (ROA) AVG 10Y
7.87%
RETURN ON ASSETS (ROA) AVG 15Y
10.55%
RETURN ON ASSETS (ROA) AVG 20Y
12.98%
CURRENT VS TTM AVG
-5.39%
CURRENT VS 3Y AVG
-45.84%
CURRENT VS 5Y AVG
-47.64%
CURRENT VS 10Y AVG
-45.37%
CURRENT VS 15Y AVG
-59.26%
CURRENT VS 20Y AVG
-66.86%
TECH Competitors' Return on Assets (ROA)
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Bio-Techne Corporation (TECH) | $11.12B | 4.30% | 4.54% | 7.94% | 8.21% |
| Insulet Corp. (PODD)vs › | $10.96B | 10.14% | 10.65% | 7.37% | 5.11% |
| Baxter International Inc. (BAX)vs › | $11.38B | -5.53% | -3.64% | -1.62% | 0.47% |
| Molina Healthcare, Inc. (MOH)vs › | $11.79B | 1.15% | 5.29% | 6.08% | 6.13% |
| Walgreens Boots Alliance, Inc. (WBA)vs › | $10.37B | -9.07% | -6.92% | -1.48% | 0.07% |
| Charles River Laboratories International, Inc. (CRL)vs › | $10.20B | -2.39% | -0.94% | 2.58% | 3.75% |
| Tempus AI, Inc. (TEM)vs › | $9.80B | -14.19% | -43.49% | -42.71% | -41.26% |
| Henry Schein, Inc. (HSIC)vs › | $9.68B | 3.49% | 3.68% | 4.39% | 5.01% |
| Revvity, Inc. (RVTY)vs › | $12.61B | 2.01% | 2.19% | 1.89% | 3.83% |
| Align Technology, Inc. (ALGN)vs › | $12.78B | 6.81% | 6.68% | 6.69% | 12.75% |
Asset Efficiency
ROA
4.3%
ROE
5.3%
Return on Assets (ROA) Formula & Definition
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Return on Assets (ROA) FAQ
- What is the return on assets (ROA) for Bio-Techne Corporation (TECH)?
- The return on assets (ROA) for TECH stock is 4.30%.
- Is Bio-Techne Corporation's return on assets (ROA) high or low?
- The return on assets (ROA) of 4.30% is 48% below its 5-year average of 8.21%, near the low end of its 5-year range (2.87%–11.86%).
- What is the TTM average return on assets (ROA) for Bio-Techne Corporation (TECH)?
- The TTM average return on assets (ROA) for TECH stock is 4.54%.
- What is the 3Y average return on assets (ROA) for Bio-Techne Corporation (TECH)?
- The 3Y average return on assets (ROA) for TECH stock is 7.94%.
- What is the 5Y average return on assets (ROA) for Bio-Techne Corporation (TECH)?
- The 5Y average return on assets (ROA) for TECH stock is 8.21%.
- What is the 10Y average return on assets (ROA) for Bio-Techne Corporation (TECH)?
- The 10Y average return on assets (ROA) for TECH stock is 7.87%.
- What is the 15Y average return on assets (ROA) for Bio-Techne Corporation (TECH)?
- The 15Y average return on assets (ROA) for TECH stock is 10.55%.
- What is the 20Y average return on assets (ROA) for Bio-Techne Corporation (TECH)?
- The 20Y average return on assets (ROA) for TECH stock is 12.98%.
TECH Return on Assets (ROA) History
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-06-30 | 2.87% |
| 2024-06-30 | 6.22% |
| 2023-06-30 | 10.81% |
| 2022-06-30 | 11.86% |
| 2021-06-30 | 6.20% |
| 2020-06-30 | 11.31% |
| 2019-06-30 | 5.10% |
| 2018-06-30 | 7.87% |
| 2017-06-30 | 4.96% |
| 2016-06-30 | 9.25% |
| 2015-06-30 | 10.13% |
| 2014-06-30 | 12.86% |
| 2013-06-30 | 14.47% |
| 2012-06-30 | 15.62% |
| 2011-06-30 | 18.18% |
| 2010-06-30 | 21.16% |
| 2009-06-30 | 22.30% |
| 2008-06-30 | 20.41% |
| 2007-06-30 | 18.71% |
| 2006-06-30 | 19.80% |
| 2005-06-30 | 22.40% |
| 2004-06-30 | 16.26% |
| 2003-06-30 | 17.24% |
| 2002-06-30 | 11.39% |
| 2001-06-30 | 15.80% |
| 2000-06-30 | 14.73% |
| 1999-06-30 | 13.49% |
| 1998-06-30 | 20.85% |
| 1997-06-30 | 20.22% |
| 1996-06-30 | 19.37% |
Related Metrics
About Bio-Techne Corporation
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was incorporated in 1976 and is headquartered in Minneapolis, Minnesota.
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Kim Kelderman